Artelo Biosciences Valuation
| ARTLWDelisted Stock | USD 0.01 0.00 0.00% |
Artelo Biosciences seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Artelo Biosciences from analyzing the firm fundamentals such as EBITDA of (10.29 M), return on equity of -0.71, and Shares Outstanding of 2.33 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Artelo Biosciences' price fluctuation is very steady at this time. Calculation of the real value of Artelo Biosciences is based on 3 months time horizon. Increasing Artelo Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Artelo stock is determined by what a typical buyer is willing to pay for full or partial control of Artelo Biosciences. Since Artelo Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Artelo Stock. However, Artelo Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0056 | Real 0.00532 | Hype 0.007616 |
The intrinsic value of Artelo Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Artelo Biosciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Artelo Biosciences helps investors to forecast how Artelo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Artelo Biosciences more accurately as focusing exclusively on Artelo Biosciences' fundamentals will not take into account other important factors: Artelo Biosciences Total Value Analysis
Artelo Biosciences is presently expected to have takeover price of 0 with market capitalization of 13.07 K, debt of 63 K, and cash on hands of 457.33 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Artelo Biosciences fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 13.07 K | 63 K | 457.33 K |
Artelo Biosciences Asset Utilization
One of the ways to look at asset utilization of Artelo is to check how much profit was generated for every dollar of assets it reports. Artelo Biosciences shows a negative utilization of assets of -0.44 percent, losing $0.004434 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Artelo Biosciences shows how discouraging it operates for each dollar spent on its assets.Artelo Biosciences Profitability Analysis
Net Loss for the year was (10.08 M) with profit before overhead, payroll, taxes, and interest of 0.About Artelo Biosciences Valuation
Our relative valuation model uses a comparative analysis of Artelo Biosciences. We calculate exposure to Artelo Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Artelo Biosciences's related companies.Artelo Biosciences, Inc., an ethical biopharmaceutical company, focuses on developing, licensing, and commercializing cannabinoid therapeutic treatments. Artelo Biosciences, Inc. was founded in 2011 and is based in La Jolla, California. Artelo Biosciences is traded on BATS Exchange in USA.
Artelo Biosciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Artelo Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 2.8 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Artelo Stock
If you are still planning to invest in Artelo Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Artelo Biosciences' history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |